-
Cy5-UTP for Fluorescent RNA Probe Synthesis
2026-08-19
Cy5-UTP enables direct, far-red visualization of RNA made by T7 in vitro transcription, simplifying probe development for FISH, multiplex imaging, and RNA-interaction studies. This workflow translates the HIDEN–IMP1–FZD5 findings into practical assay choices while highlighting controls that protect RNA integrity and biological interpretation.
-
Rosiglitazone A4304 for Reliable Cell Assays
2026-08-19
Rosiglitazone (SKU A4304) supports reproducible PPARγ-focused studies while helping researchers distinguish metabolic modulation from genuine changes in cell number. This scenario-driven guide covers solvent preparation, assay design, interpretation, and practical reagent selection for adipogenesis, cytotoxicity, and type II diabetes research.
-
BAPTA Calcium Chelator for Apoptosis Studies
2026-08-18
BAPTA provides a practical way to test whether altered Ca2+ is a driver of toxicant-induced apoptosis rather than a secondary signal. This workflow translates the IP3R/Ca2+/STAT3 findings in intestinal cells into controlled exposure, rescue, and troubleshooting strategies for calcium signaling modulation.
-
Nonselective β-Blockers and Hematopoietic Regeneration
2026-08-18
Nishino and colleagues show that nonselective β-adrenergic receptor inhibition can delay hematopoietic regeneration after allogeneic transplantation, whereas β1-selective blockade had substantially less effect in the tested models. The study connects sympathetic niche signaling with transplant outcomes and suggests that blocker selectivity, conditioning context, and graft-cell dose should be considered in translational research.
-
A40926 Workflow for Antibacterial Research
2026-08-17
A40926 combines direct glycopeptide activity with value as a dalbavancin precursor, making it useful for MIC benchmarking, MRSA research, and pathway-focused antibiotic development. This practical workflow emphasizes controlled dilution design, endpoint separation, and troubleshooting for reproducible Gram-positive and Neisseria gonorrhoeae studies.
-
Poly-PR, TDP-43 Condensation, and HSP70 Activity
2026-08-17
Agnihotri et al. show that C9ORF72-associated poly-PR promotes NEAT1-dependent TDP-43 nuclear condensates and that HSP70 initially preserves their fluidity before becoming displaced during sustained stress. The study connects altered phase separation with TDP-43 oligomerization, mislocalization, and poly-PR toxicity, providing a mechanistic framework for studying chaperone control of ALS- and FTD-related proteinopathy.
-
LY2228820: Rethinking p38 MAPK Translation
2026-08-16
LY2228820 is more than a pathway inhibitor: it is a practical probe for connecting p38α/β target engagement with inflammatory, stress-response, angiogenic, and tumor phenotypes. This thought-leadership analysis integrates product evidence with emerging structural insights into kinase dephosphorylation, offering translational researchers a framework for assay design, biomarker selection, and preclinical decision-making without overstating the current evidence.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-15
ARCA Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 tracking of the delivered transcript with EGFP-based measurement of productive translation. This guide translates that dual-readout design into practical workflows for mRNA transfection in mammalian cells, formulation screening, microscopy, flow cytometry, and troubleshooting.
-
Icariin–PDE5A Signaling in Spermatogonial Stem Cells
2026-08-15
A 2025 study identifies PDE5A as a molecular target through which icariin influences mouse spermatogonial stem cell viability, DNA synthesis, and oxidative DNA damage. By integrating stem-cell experiments, surface plasmon resonance imaging, molecular docking, oxidative-stress modeling, and in vivo validation, the work connects a traditional medicine compound with a defined regulatory pathway relevant to male reproductive biology.
-
Nonselective β-Blockade Delays HCT Engraftment
2026-08-14
The reference study shows that nonselective β-adrenergic inhibition can impair hematopoietic regeneration after transplantation, whereas β1-selective inhibition with metoprolol did not produce the same effect in the tested mouse and human settings. Its comparative mouse–clinical design links receptor selectivity, transplant type, graft-versus-host disease prophylaxis, and cell dose to engraftment outcomes.
-
Cyclosporin (B8309): Reliable Assay Design
2026-08-13
This scenario-driven guide explains how Cyclosporin (SKU B8309) can support reproducible studies of T-cell signaling, mitochondrial function, viability, and cytotoxicity. It connects mechanism, concentration selection, controls, interpretation, and vendor evaluation to published evidence and practical laboratory decisions.
-
Gepotidacin Workflows for Resistance Research
2026-08-13
Build more informative antibacterial assays with Gepotidacin, from MIC testing and topoisomerase biochemistry to resistance profiling. This guide connects mechanism-specific readouts with translational pharmacokinetic considerations for reproducible antibiotic resistance research.
-
Dual Recombinase Tracing Finds No Mouse Neo-Oogenesis
2026-08-13
Xie, Zhou, and Zheng use orthogonal Cre-loxP and Dre-rox lineage tracing to test whether postnatal mouse ovarian cells generate new oocytes. Across physiological aging and busulfan-induced ovarian injury, no labeled growing oocytes or metaphase II eggs were detected, providing strong in vivo evidence against postnatal neo-oogenesis in mice.
-
Fucoidan Workflows for Cancer and Viral Assays
2026-08-12
Explore practical Fucoidan workflows for apoptosis, immune activity, angiogenesis, and exploratory herpesvirus nuclear-egress assays. The guide combines product-handling controls with a mechanism-aware strategy for separating cytotoxicity from membrane-fusion effects.
-
SAR131675: Mapping VEGFR-3 Across Fibrosis and Cancer
2026-08-12
SAR131675 offers a selective pharmacology framework for testing how VEGFC–VEGFR-3 signaling connects lymphangiogenesis, macrophage behavior, fibrosis, and tumor biology. This thought-leadership guide translates its mechanistic evidence into practical study-design guidance while keeping translational maturity and safety limitations in view.
446 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page